Journal of Korean Traditional Oncology (대한암한의학회지)

Korean Association of Traditional Oncology (대한암한의학회)
권호 표지
DOI QR코드

DOI QR Code

A case study on a metastatic adrenocortical carcinoma patient treated by Wheel Balanced Cancer Therapy with improvement of quality of life and related symptoms

수레바퀴 암치료법을 시행한 전이성 부신피질암 환자의 증상 개선 및 삶의 질 향상에 대한 증례보고

  • Ha, Su-jeong (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Song, Si-yeon (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Park, So-jung (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Jeon, Hyung-joon (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Lee, Yeon-weol (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Cho, Chong-kwan (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Yoo, Hwa-seung (East West Cancer center, Dunsan Korean Medicine Hospital of Daejeon University)
  • 하수정 (대전대학교 둔산한방병원 동서암센터) ;
  • 송시연 (대전대학교 둔산한방병원 동서암센터) ;
  • 박소정 (대전대학교 둔산한방병원 동서암센터) ;
  • 전형준 (대전대학교 둔산한방병원 동서암센터) ;
  • 이연월 (대전대학교 둔산한방병원 동서암센터) ;
  • 조종관 (대전대학교 둔산한방병원 동서암센터) ;
  • 유화승 (대전대학교 둔산한방병원 동서암센터)
  • Received : 2018.12.03
  • Accepted : 2018.12.18
  • Published : 2018.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: The purpose of this study is to report a metastatic adrenocortical carcinoma patient treated with wheel balanced cancer therapy (WBCT) regimen. Methods: A 52-year-old female patient diagnosed and incised with metastatic adrenocortical carcinoma visited the East West Cancer Center (EWCC) on Sep. 1st, 2018 for WBCT. The patient was treated with WBCT for an approximately 2 months, from Sep. 1st to Nov. 9th. Computed tomography (CT) was used to follow-up the tumor site. Laboratory analysis and National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), version 5.0 were used to evaluate the safety of WBCT. Results: The surgical beds after surgery (Lt. Laparoscopic adrenalectomy) were maintained without recurrence at follow up chest CT, and related symptoms and quality of life (QOL) were improved during the WBCT. Conclusion: This case study suggests that WBCT may help to improve QOL of adrenocortical carcinoma patient.

Keywords

HJJJCF_2018_v23n2_35_f0001.png 이미지

Figure 1. Chest Computed Tomography

Table 1. Laboratory Findings

HJJJCF_2018_v23n2_35_t0001.png 이미지

Table 2. Wheel Balance Cancer Therapy Regimen

HJJJCF_2018_v23n2_35_t0002.png 이미지

References

  1. Bilimoria KY, Shen WT , Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, Sturgeon C. Adrenocortical carcinoma in the United States. Cancer 113 (11) : 3130-3136, 2008 https://doi.org/10.1002/cncr.23886
  2. Kendrick ML, Lloyd R, Erickson L, et al. Adrenocortical carcinoma: surgical progress or status quo? Arch Surg. 136 : 543-549, 2001 https://doi.org/10.1001/archsurg.136.5.543
  3. Jensen JC,Pass HI,Sindelar WF,Norton JA. Recurrent or metastatic disease in select patients with adrenocortical carcinoma. Aggressive resection vs chemotherapy. Arch Surg. 126 : 457-461, 1991 https://doi.org/10.1001/archsurg.1991.01410280059008
  4. Allolio B, Fassnacht M: Clinical review: Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91 (6) : 2027-2037, 2006 https://doi.org/10.1210/jc.2005-2639
  5. Fassnacht M, Allolio B: Epidemiology of adrenocortical carcinoma. In: Hammer GD, Else T, eds.: Adrenocortical Carcinoma: Basic Science and Clinical Concepts. New York, Springer, 23-29, 2010
  6. Yoo HS, Cho CK, Hong MS. Review of the best case series methodology : best case series results of East-West Cancer Center. Integr Cancer Ther 7 (3): 182-188, 2008 https://doi.org/10.1177/1534735408322844
  7. Park JS, Yoo HS, Lee YW, Cho JH, Son CG, Cho CK. Wheel Balance Cancer Therapy in the treatment of metastatic gastric carcinoma : A retrospective analysis of 62 patients. Korean J Orient Int Med 28 (3) : 531-543, 2007
  8. Park BK, Yoo HS, Lee YW, Han SS, Cho JH, Son CG, Cho CK. Retrospective cohort analysis for lung cancer patients treated with Wheel Balance Therapy (WBT). Korean J Orient Int Med 19 (2) : 45-56, 2009
  9. Brennan VC, Wang CM, Yang WH. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-${\alpha}$ serine/threonine-protein kinase signaling. J Med Food 15 (4) : 325-334, 2012 https://doi.org/10.1089/jmf.2011.0158
  10. National Cancer Institute. Common Terminology Criteria for Adverse Events(CTCAE) v.5.0, 2017. Available fromhttps://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_5.0/
  11. Park HM, Kim SY, Jung IC, Lee YW, Cho CK, Yoo HS. Integrative tumor board : a case report and discussion from East-West Cancer Center. Integr Cancer Ther 9 (2) : 236-245, 2010 https://doi.org/10.1177/1534735410371479
  12. Konda B, Kirschner LS. Novel targeted therapies in adrenocortical carcinoma. Curr Opin Endocrinol Diabetes Obes 23 (3) : 233-241, 2016 https://doi.org/10.1097/MED.0000000000000247
  13. Yoo HS, Lee YW, Song KC, Choi BL, Seo SH, Cho JH, Lee YW, Son CG, Cho CK. The effects of HangAmDan(HAD) on anti-metastasis and preventing relapses, administered to 69 cancer patients. Korean J Orient Int Med 23 (2) : 165-173, 2002
  14. Yoo HS, Lee HJ, Kim JS, Yoon J, Lee GH, Lee YW, Cho CK. Toxicological study on HangAmDan-B in mice. J Acupunct Meridian Stud 4 (1) : 54-60, 2011 https://doi.org/10.1016/S2005-2901(11)60007-1
  15. Son CG, Shin JW, Cho JH, Cho CK, Yun CH, Chung W, Han SH. Macrophage activation and nitric oxide production by water soluble components of Hericium erinaceum. Int Immunopharmacol 6 (8) : 1363-1369, 2006 https://doi.org/10.1016/j.intimp.2006.03.005
  16. Yim MH, Shin JW, Son JY, Oh SM, Han SH, Cho JH, Cho CK, Yoo HS, Lee YW, Son CG. Soluble components of Hericium erinaceum induce NK cell activation via production of interleukin-12 in mice splenocytes. Acta Pharmacol Sin 28 (6) : 901-907, 2007 https://doi.org/10.1111/j.1745-7254.2007.00577.x
  17. Khan N, Afaq F, Syed DN, Mukhtar H. Fisetin, a novel dietary flavonoid, causes apoptosis and cell cycle arrest in human prostate cancer LNCaP cells. Carcinogenesis 29(5):1049-1056, 2008 https://doi.org/10.1093/carcin/bgn078
  18. Suh Y, Afaq F, Johnson JJ, Mukhtar H. A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways. Carcinogenesis 30 (2) : 300-307, 2009 https://doi.org/10.1093/carcin/bgn269
  19. Murtaza I, Adhami VM, Hafeez BB, Saleem M, Mukhtar H. Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-kappaB. Int J Cancer 125 (10) : 2465-2473, 2009 https://doi.org/10.1002/ijc.24628